Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
Last trade$31.45
Day change-$1.32 (-4.03%)
Day range$29.33 – $33.00
Volume1,419,723
Market cap$5.85B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$5.85B
Price / earnings
41.85×
Price / book
6.3×
Price / sales
8.84×
EV / sales
8.51×
EV / EBITDA
27.33×
Profitability
Earnings per share
$0.78
Return on assets
12.8%
Return on equity
15.05%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0×
Current ratio
6.37×
Quick ratio
6.37×
Cash ratio
1.51×
Cash flow
Price / cash flow
19.13×
Price / free cash flow
19.13×
Free cash flow
$305.62M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for DOCS, quarterly periods
Line item
Q2 FY2027 Sep 30, 2026
Q1 FY2027 Jun 30, 2026
Q4 FY2026 Mar 31, 2026
Q3 FY2026 Dec 31, 2025
Q2 FY2026 Sep 30, 2025
Q1 FY2026 Jun 30, 2025
Q4 FY2025 Mar 31, 2025
Q3 FY2025 Dec 31, 2024
Revenue
$174.54M
$156.62M
$145.37M
$185.05M
$168.53M
$145.91M
$138.29M
$168.6M
Cost of revenue
$25.35M
$23.69M
$19.41M
$18.7M
$16.43M
$15.79M
$14.47M
$14.18M
Gross profit
$149.19M
$132.93M
$125.97M
$166.35M
$152.1M
$130.12M
$123.82M
$154.42M
Selling, general and administrative
$63.31M
$60.81M
$62.03M
$59.86M
$58.22M
$48.8M
$50.34M
$52.08M
Research and development
$41.96M
$38.48M
$39.11M
$34.6M
$30.2M
$26.8M
$24.8M
$22.42M
Total operating expenses
$105.27M
$99.28M
$101.14M
$94.46M
$88.42M
$75.6M
$75.14M
$74.5M
Operating income
$43.92M
$33.64M
$24.83M
$71.9M
$63.68M
$54.52M
$48.68M
$79.93M
Interest expense
$0
$0
$0
$0
$0
$0
$0
$0
Income before taxes
$50.33M
$40.36M
$32.12M
$80.8M
$72.94M
$64.15M
$58.39M
$89.84M
Income taxes
$15.6M
$16.05M
$13.01M
$19.24M
$10.88M
$10.83M
-$4.06M
$14.64M
Net income
$34.73M
$24.32M
$19.11M
$61.56M
$62.06M
$53.32M
$62.46M
$75.2M
Net income attributable to common shareholders
$34.73M
$24.32M
$19.11M
$61.56M
$62.06M
$53.32M
$62.46M
$75.2M
EBITDA
$56.43M
$37.93M
$33.16M
$78.38M
$73.92M
$57.31M
$54.93M
$84.37M
Basic earnings per share
$0.19
$0.13
$0.10
$0.33
$0.33
$0.28
$0.33
$0.40
Diluted earnings per share
$0.18
$0.13
$0.10
$0.31
$0.31
$0.27
$0.31
$0.37
Recent news
Company coverage with links to the original publishers.
A class action lawsuit has been filed against Doximity, Inc. alleging that the company made false and misleading statements regarding its Newsfeed's impact on revenue growth, market share losses to competitors, and reliance on banner advertisements and email newsletters. The lawsuit covers investors who purchased Doximity securities between August 8, 2024 and May 13, 2026. Investors have until November 16, 2026 to request appointment as lead plaintiff.
Doximity announced an expansion of its AI-powered clinical tools partnership with NewYork-Presbyterian, Columbia University, and Weill Cornell Medicine. The collaboration includes Doximity Ask (clinical decision support integrated with Epic EHR) and Doximity Scribe (patient documentation and dictation). The company also launched DoseCheck, a safety feature reducing dosing errors by over 99%. Despite the positive developments, DOCS stock has declined 24.7% year-to-date.
Rosen Law Firm reminds Doximity, Inc. investors who purchased stock between August 8, 2024 and May 13, 2026 of the November 16, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Doximity overstated the revenue impact of its Newsfeed feature and was losing market share to competitors while relying on less effective advertising methods.
The global telehealth market is experiencing significant growth, projected to expand from $77.4 billion in 2025 to $187.5 billion by 2033. Key developments include AI-powered diagnostics, remote patient monitoring, and virtual care expansion. Rocket Doctor AI joined the Altais network to expand telehealth services in California, while competitors like Teladoc Health, Amwell, Hims & Hers, and Doximity launched new AI capabilities and research initiatives to enhance digital healthcare delivery.
Rosen Law Firm has issued deadline notices for securities class action lawsuits against Doximity, Inc. and Ardelyx, Inc., with a November 16, 2026 lead plaintiff deadline. The firm is also announcing a newly filed lawsuit against NVIDIA Corporation. Investors who purchased shares during specified class periods may be eligible for compensation.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.